Back to rankings

Nippon Kayaku Co., Ltd. (NPKYF)

POSITIVE
Basic MaterialsChemicalsJapan

Price

$2130.50

Market Cap

$316.01B

Fundamental

69

Technical

75

Composite

71

AI Analysis

Generated on demand using your Gemini API key

Gemini API key not configured

Add your Gemini API key in Settings to unlock AI analysis.

Overview

Nippon Kayaku Co., Ltd. engages in mobility and imaging, fine chemicals, and life sciences businesses in Japan. The company offers airbag inflators, micro gas generators for seatbelt pretensioners and squib; and liquid crystal display (LCD) projector and display, and x-ray analysis system components. It also provides epoxy and maleimide resin, epoxy resin hardener, reactive flame retardant, acrylic acid esters, UV-curable resins for resist, resist for MEMS, cleaners for LCDs and semiconductors, and LCD sealants, as well as semiconductor manufacturing equipment, such as laminator, remover, mounter, UV irradiation equipment; colorants for inkjet printers, dyes for inkjet textile printing, inks for industrial inkjet printers, image sensor materials, dichotomous colorants for dimmable glass, near infrared absorbers, dyes for textiles and paper, colorants for resins, developers for thermal paper, and pigment derivative; and catalysts for the production of acrylic acid, acrolein, and methacrylic acid. In addition, the company offers Anti-cancer and biological drugs, cardiovascular and photodynamic diagnostic agents, in-vitro diagnostic drugs, embolization materials, pharmaceutical API and intermediates, food additives, health food ingredients, preservatives for food quality, and cleaners and disinfectants; Insecticides, herbicides, fungicides, miticides, public health insecticides, soil fumigants, and animal repellents; and engages in real estate business. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.

Balance Sheet & Liquidity

Revenue

$222.58B

Net Income

$17.51B

Free Cash Flow

$-5.48B

Total Equity

$267.53B

Total Liabilities

$105.19B

Current Ratio

3.72

Interest Coverage

91.08

Debt/EBITDA

2.90

Earnings Per Share

Revenue & Net Income

Free Cash Flow

Income Breakdown

Fair Value Estimation

Undervalued

Fair Value

$3024.32

Current Price

$2130.50

Margin of Safety

+29.6%

Fair Value Range

$1965.81 - $4082.84

Estimation Methods

Analyst Target:N/A
DCF:$3111.40
PE-based:$2109.90
Graham Growth:$6018.13
EPV:$1315.08
Analyst Consensus:Strong Buy (4B / 1H / 0S)
Last Earnings Surprise:+37.28%

Valuation Metrics

P/E Ratio

19.88

ROE

6.5%

P/B Ratio

1.27

P/FCF

-

Gross Margin

32.1%

ROIC

5.1%

Value Creation (Economic Moat)

ROIC

5.1%

WACC

6.5%

ROIC − WACC

-1.5 pp

ROIC is below the cost of capital — the company is destroying value for every dollar invested.

Fundamental Analysis Criteria

Passed (18)

  • EPS shows upward trend
  • ROIC 5.1%
  • Gross Margin 32.1%
  • P/B Ratio 1.27
  • Debt/Equity ratio
  • Operating Margin 9.2%
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • ROE 9.1%
  • Revenue Growth 5Y 6.9%
  • Analyst Consensus 80% Buy
  • Earnings Surprise avg 37.3%
  • PEG Ratio 0.72
  • Earnings Quality (OCF/NI) 1.46
  • Share Dilution -1.5%
  • Net Margin Trend 7.9% vs 2.0%
  • Piotroski F-Score 8/9

Failed (5)

  • EPS CAGR 1.76%
  • Price CAGR 3.73%
  • Positive Free Cash Flow
  • Price below Graham Number
  • DCF valuation (Overvalued)

Unavailable (5)

  • P/FCF NaN
  • Dividend Payout NaN%
  • CapEx intensity
  • Return on Tangible Assets
  • Low reliance on intangibles

Price Chart

Technical Indicators

RSI (14)

62.11

SMA 50

$1923.10

SMA 200

$1696.67

MACD

-9.80

Volatility

2.0%

Momentum (12m)

63.7%

RSI 62.1, SMA trend bullish, momentum 63.7%.

Piotroski F-Score

8/9

Strong financial health

score
criteria

Earnings Quality

1.46

High quality: earnings backed by cash

Share Dilution

-150.0%

Buying back shares. Shareholder friendly

Governance

Executive Team

NameTitleAge
Mr. Shigeyuki KawamuraPresident, CEO & Director62
Mr. Tsutomu KawamuraGeneral Manager of Finance & Accounting Division-
Yasuhito KatoMD of Technology & Director60
Ichio KohinataGeneral Manager of Legal Affairs Division-
Shinji InoueSenior Executive Officer of planning, Corp. Communication & Accounting and Director59
Makoto TakedaMD of Human Resource & Director61
Hiroshi ShimadaSenior MD, Head of Pharmaceuticals Group & Director60
Hideyuki YuyaMD & Head of Polatechno Group-
Shigehide KagayaHead of Catalysts Group, Fine Chemicals Business Unit-
Yoshiki AkataniManaging Director of Fine Chemicals Business Area-

Audit Risk

1

Board Risk

9

Compensation Risk

1

Shareholder Rights Risk

2

Latest News

Recent headlines for NPKYF, sourced from Markets Gazette.

No recent news for NPKYF.
Disclaimer

This platform is for educational purposes only. It does not provide financial, investment, or trading advice. All scores, valuations, and signals are based on automated analysis of publicly available data that may be incomplete or inaccurate. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Created by CODEPRESS s.r.l.